e-we thrombin
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 30, 2018 (NCT03453060)
Timeline
Indications
Mechanism of action
- ThrombinSupplementation
F2 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03963895 | Phase 2 | Jun 30, 2019 | Aronora, Inc., Celerion |
| NCT03453060 | Phase 1 | May 30, 2018 | Aronora, Inc., Celerion |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aronora, Inc. | For profit | 2 | 2 | 2 | 2018 |
| Celerion | For profit | 2 | 0 | 2 | 2018 |
2 organizations
Page 1 / 1